Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
This type of reaction often points to issues with the products purity, reconstitution with non-sterile water, or improper administration technique
Treatments for hyperpigmented lips include topical creams, chemical peels, laser therapy, and cryotherapy
Eslicarbazepine: Higher affinity for the inactive state of the voltage-sensitive sodium channel (causing greater inhibitory effect on rapidly firing neurons
Shop the KLOW Blend (GHK-Cu, TB-500, BPC-157, KPV) in 80mg vials from Eternal Peptides